United Laboratories International Holdings Limited disclosed a share repurchase on 16 June 2026, acquiring 500,000 ordinary shares on the Hong Kong Stock Exchange.
The shares were repurchased at prices ranging between HK$8.29 and HK$8.40, translating to a volume-weighted average cost of HK$8.3664 per share and an aggregate cash outlay of HK$4.18 million. The repurchased stock, earmarked for cancellation, represents approximately 0.03% of the company’s 1.97 billion issued shares as at 31 May 2026. No treasury shares were held before or after the transaction.
The move was executed under the general mandate granted on 25 June 2025, which permits the repurchase of up to 181.70 million shares. To date, 500,000 shares—equivalent to 0.03% of the authorised limit—have been bought back. In line with Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, effective until 16 July 2026.
United Laboratories’ board confirmed that the transaction adhered to all applicable regulations and that no material changes have occurred to the repurchase mandate’s explanatory statement previously filed with the Exchange.
Comments